Biomolecular Screening and Alternative Approaches for the National Toxicology Program

$4,866,268ZIAFY2017ESNIH

National Institute Of Environmental Health Sciences

Investigators

Linked publications, trials & patents

Paper 34242083 Paper 34165557 Paper 33929906 Paper 33511999 Paper 33452530 Paper 31325560 Paper 31277893 Paper 31243984 Paper 31201879 Paper 31195068 Paper 31188086 Paper 31136631 Paper 31058248 Paper 31016663 Paper 31009485 Paper 30964323 Paper 30944845 Paper 30943442 Paper 30850835 Paper 30653989 Paper 30578838 Paper 30570668 Paper 30521027 Paper 30496580 Paper 30420870 Paper 30329029 Paper 30321397 Paper 30312655 Paper 30205137 Paper 30205136 Paper 30202884 Paper 30170118 Paper 30169818 Paper 30099088 Paper 30059008 Paper 30045675 Paper 29957589 Paper 29908304 Paper 29870792 Paper 29868454 Paper 29790904 Paper 29752982 Paper 29678766 Paper 29668046 Paper 29596651 Paper 29529324 Paper 29474122 Paper 29462216 Paper 29426857 Paper 29423527 Paper 29408321 Paper 29385628 Paper 29377626 Paper 29363186 Paper 29351317 Paper 29346762 Paper 29326230 Paper 29203341 Paper 29127450 Paper 29114260 Paper 29110506 Paper 29106658 Paper 29077947 Paper 28927277 Paper 28751236 Paper 28714573 Paper 28686730 Paper 28633424 Paper 28531190 Paper 28478275 Paper 28477266 Paper 28346099 Paper 28259702 Paper 28055944 Paper 27846345 Paper 27829164 Paper 27780885 Paper 27566445 Paper 27481070 Paper 27462126 Paper 27384688 Paper 27343050 Paper 27328013 Paper 27258438 Paper 27122658 Paper 27099258 Paper 27091369 Paper 26985019 Paper 26978842 Paper 26927286 Paper 26865669 Paper 26854185 Paper 26690555 Paper 26662846 Paper 26448092 Paper 26386178 Paper 26260164 Paper 26254731 Paper 26243743 Paper 26212309

Abstract

The NTP Biomolecular Screening Branch (BSB) develops and carries out programs in medium and high throughput screening (HTS) of environmental substances for rapid detection of biological activities of significance to toxicology. The BSB specifically administers the NTP HTS program initiative to implement its vision for toxicology in the 21st century; this vision places an increased emphasis on the use of alternative assays for targeting the key pathways, molecular events, or processes linked to disease or injury, and attempts to incorporate them into a research and testing framework.

View original record on NIH RePORTER →